Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
ACC 26: RECOVER-Autonomic - Ivabradine for Post-COVID POTS
Author(s): Pam Taub Added: 1 month ago
American College of Cardiology Congress 2026 – Dr Pam Taub (University of California San Diego, La Jolla, US) joins us to discuss results from the RECOVER-Autonomic platform trial (NCT06305806; Kanecia Obie Zimmerman), evaluating the impact of ivabradine on orthostatic intolerance, quality of life, and heart rate in post-COVID POTS.This randomised, placebo-controlled appendix trial enrolled 181… View more

Prevention & Chronic Conditions

COVID-19
COVID-19 and Cardiovascular Care in Asia-Pacific
Author(s): Mitsuaki Sawano , Misato Chimura , Jonathan Yap , et al Added: 1 year ago

Imaging & Diagnostics

Prevention & Chronic Conditions
COVID-19 and Acute Aortic Dissection: Early Outcomes
Author(s): An Thai Nguyen , Hau Tien Nguyen , Vu Tuan Le Added: 1 week ago

Intervention

Vascular Disease and Surgery
Post-COVID-19 Myocarditis Identified using CMR
Author(s): Reynald Evan R Tugade , Nyssa Elline Palileo , Danica Ann Leycano , et al Added: 1 year ago

Imaging & Diagnostics
ECG in Severe COVID-19 Infection
Author(s): Kapil Rajendran , Baiju Rajan , Sivaprasad Kunjukrishnapilla , et al Added: 1 year ago

Imaging & Diagnostics

Electrophysiology & Arrhythmia
AF Symposium 26: ADVENT LTO: Long-Term PFA Outcomes and AF Progression
Author(s): Vivek Reddy Added: 3 months ago
AF Symposium 2026 - Dr Vivek Reddy (Icahn School of Medicine at Mount Sinai, New York, NY, US) joins us to discuss findings from the ADVENT LTO study, evaluating long-term outcomes and atrial fibrillation progression in patients who received ablation with the FARAPULSE Pulsed Field Ablation System compared to thermal ablation.The study tracked AF progression patterns, arrhythmia recurrence rates,… View more

Electrophysiology & Arrhythmia
ECO 24: Long-Term Weight Loss in the SELECT trial
Author(s): Donna H Ryan Added: 1 year ago
ECO 2024 — Dr Donna H Ryan (Pennington Biomedical Research Center, US) joins us to discuss the first sub-analysis of the landmark SELECT trial (NCT03574597, Novo Nordisk).In this study, investigators looked at long-term weight loss with semaglutide 2.4 mg compared to a placebo among 17,604 participants. In SELECT, at 208 weeks, semaglutide produced clinically significant weight loss compared to… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Post-ACS Discharge and Long-term Follow-up Recommendations for Thailand
Author(s): Rungroj Krittayaphong , Wacin Buddhari , Bancha Sookananchai , et al Added: 1 year ago

Intervention

MI/ACS
Added: 1 month ago Source:  Interventional Cardiology Review Journal
Long-term follow-up from the FAMOUS-NSTEMI trial suggests that a fractional flow reserve-guided strategy for managing patients with non-ST-segment elevation myocardial infarction (NSTEMI) does not reduce adverse cardiovascular outcomes compared to standard angiography-guided care.¹MethodologyFAMOUS-NSTEMI was a prospective, randomised, controlled trial that enrolled 350 patients with NSTEMI… View more

Intervention

MI/ACS
TCT 2025: INFINITY-SWEDEHEART: Long-Term Bioadaptor Outcomes
Author(s): David Erlinge Added: 6 months ago
TCT 2025 - Findings from INFINITY-SWEDEHEART show significant reductions in target vessel failure and treatment benefit after 6 months to two years with the DynamX bioadaptor stent.Prof David Erlinge (Skane University Hospital, SE) joins us to discuss findings from the INFINITY-SWEDEHEART trial, a prospective, multicenter, registry-based randomized clinical trial comparing long-term outcomes of… View more

Intervention

MI/ACS